Literature DB >> 22038335

C-reactive protein as a predictor of cardiovascular events in elderly patients with chronic kidney disease.

Diana Jalal1, Michel Chonchol, Thorleif Etgen, Dirk Sander.   

Abstract

BACKGROUND: Few studies have evaluated the relationship between high-sensitivity C-reactive protein (hs-CRP) and vascular events in the elderly with chronic kidney disease (CKD).
METHODS: The association of hs-CRP with vascular events was examined according to CKD status in 3,166 participants of the Intervention Project on Cerebrovascular Diseases and Dementia in the Community of Ebersberg, Bavaria (INVADE study). CKD was defined as a creatinine clearance <60 ml/min estimated by the Cockcroft-Gault formula. hs-CRP was used as a binary variable > or <2.1 mg/L (median value). Vascular events were defined as a composite of myocardial infarction, stroke and vascular death.
RESULTS: After 4 years of follow-up, 204 participants (6.4%) experienced a major cardiovascular event. High hs-CRP levels and CKD at baseline were associated with a greater risk of vascular events. Compared with patients with low hs-CRP and non-CKD, the adjusted hazard ratio (95% confidence interval) for vascular events was 1.42 (1.11-2.21) for low hs-CRP and CKD, 1.57 (1.21-2.34) for high hs-CRP and non-CKD and 1.93 (1.45-2.89) for high hs-CRP and CKD.
CONCLUSIONS: These results suggest that high hs-CRP levels provide prognostic information in patients with CKD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22038335      PMCID: PMC3704176          DOI: 10.5301/jn.5000047

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  38 in total

1.  Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis: the INVADE study.

Authors:  Dirk Sander; Carla Schulze-Horn; Horst Bickel; Hans Gnahn; Eva Bartels; Bastian Conrad
Journal:  Stroke       Date:  2005-12-22       Impact factor: 7.914

2.  C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase.

Authors:  Erion Qamirani; Yi Ren; Lih Kuo; Travis W Hein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-17       Impact factor: 8.311

3.  C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease.

Authors:  Vandana Menon; Tom Greene; Xuelei Wang; Arema A Pereira; Santica M Marcovina; Gerald J Beck; John W Kusek; Alan J Collins; Andrew S Levey; Mark J Sarnak
Journal:  Kidney Int       Date:  2005-08       Impact factor: 10.612

4.  C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy.

Authors:  Allon N Friedman; Lawrence G Hunsicker; Jacob Selhub; Andrew G Bostom
Journal:  Kidney Int       Date:  2005-08       Impact factor: 10.612

5.  Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors.

Authors:  Michael G Shlipak; Linda F Fried; Mary Cushman; Teri A Manolio; Do Peterson; Catherine Stehman-Breen; Anthony Bleyer; Anne Newman; David Siscovick; Bruce Psaty
Journal:  JAMA       Date:  2005-04-13       Impact factor: 56.272

6.  Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study.

Authors:  Paul Muntner; Jiang He; Brad C Astor; Aaron R Folsom; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2004-12-29       Impact factor: 10.121

7.  CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.

Authors:  Adam T Whaley-Connell; James R Sowers; Lesley A Stevens; Samy I McFarlane; Michael G Shlipak; Keith C Norris; Shu-Cheng Chen; Yang Qiu; Changchun Wang; Suying Li; Joseph A Vassalotti; Allan J Collins
Journal:  Am J Kidney Dis       Date:  2008-04       Impact factor: 8.860

8.  The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD.

Authors:  Daniel E Weiner; Hocine Tighiouart; Essam F Elsayed; John L Griffith; Deeb N Salem; Andrew S Levey; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2008-02       Impact factor: 8.860

9.  Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP).

Authors:  Peter A McCullough; Claudine T Jurkovitz; Pablo E Pergola; Janet B McGill; Wendy W Brown; Alan J Collins; Shu-Cheng Chen; Suying Li; Ajay Singh; Keith C Norris; Michael J Klag; George L Bakris
Journal:  Arch Intern Med       Date:  2007-06-11

10.  Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinine.

Authors:  Sandra V Giannelli; Kushang V Patel; B Gwen Windham; Francesco Pizzarelli; Luigi Ferrucci; Jack M Guralnik
Journal:  J Am Geriatr Soc       Date:  2007-06       Impact factor: 5.562

View more
  8 in total

1.  Serum C-reactive protein levels in pre-dialysis chronic kidney disease patientsin southern Nigeria.

Authors:  Oluseyi A Adejumo; Enajite I Okaka; Chimezie G Okwuonu; Ikponmwosa O Iyawe; Oluwole O Odujoko
Journal:  Ghana Med J       Date:  2016-03

2.  MicroRNAs 223-3p and 93-5p in patients with chronic kidney disease before and after renal transplantation.

Authors:  M Ulbing; A H Kirsch; B Leber; S Lemesch; J Münzker; N Schweighofer; D Hofer; O Trummer; A R Rosenkranz; H Müller; K Eller; V Stadlbauer; B Obermayer-Pietsch
Journal:  Bone       Date:  2016-11-17       Impact factor: 4.398

3.  Microscopic Haematuria and Clinical Outcomes in Patients With Stage 3-5 Nondiabetic Chronic Kidney Disease.

Authors:  Hugo You-Hsien Lin; Chun-Yu Yen; Lee-Moay Lim; Daw-Yang Hwang; Jer-Chia Tsai; Shang-Jyh Hwang; Chi-Chih Hung; Hung-Chun Chen
Journal:  Sci Rep       Date:  2015-10-16       Impact factor: 4.379

4.  Detection of pro angiogenic and inflammatory biomarkers in patients with CKD.

Authors:  Diana Jalal; Bridget Sanford; Brandon Renner; Patrick Ten Eyck; Jennifer Laskowski; James Cooper; Mingyao Sun; Yousef Zakharia; Douglas Spitz; Ayotunde Dokun; Massimo Attanasio; Kenneth Jones; Joshua M Thurman
Journal:  Sci Rep       Date:  2021-04-22       Impact factor: 4.996

5.  New oral spherical carbon adsorbent effectively reduces serum indoxyl sulfate levels in moderate to advanced chronic kidney disease patients: a multicenter, prospective, open-label study.

Authors:  Seok-Hyung Kim; Jong Hyun Jhee; Hoon Young Choi; Sang-Ho Lee; Sug Kyun Shin; So-Young Lee; Dong Ho Yang; Joo-Hark Yi; Sang-Woong Han; Young-Il Jo; Hyeong Cheon Park
Journal:  BMC Nephrol       Date:  2020-07-31       Impact factor: 2.388

6.  Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease.

Authors:  Diana Jalal; Brandon Renner; Jennifer Laskowski; Erik Stites; James Cooper; Karissa Valente; Zhiying You; Loni Perrenoud; Moglie Le Quintrec; Ismaeel Muhamed; Uwe Christians; Jelena Klawitter; Margaret A Lindorfer; Ronald P Taylor; V Michael Holers; Joshua M Thurman
Journal:  J Am Heart Assoc       Date:  2018-07-13       Impact factor: 5.501

7.  Correlations between serum inflammatory markers and comorbidities in patients with end-stage renal disease.

Authors:  Asmahan K Eloueyk; Rashad Y Alameddine; Bilal A Osta; Dania M Awad
Journal:  J Taibah Univ Med Sci       Date:  2019-11-11

Review 8.  Diabetic patients with chronic kidney disease: Non-invasive assessment of cardiovascular risk.

Authors:  Nejc Piko; Sebastjan Bevc; Robert Ekart; Tadej Petreski; Nina Vodošek Hojs; Radovan Hojs
Journal:  World J Diabetes       Date:  2021-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.